Exact Mass: 556.2324782

Exact Mass Matches: 556.2324782

Found 500 metabolites which its exact mass value is equals to given mass value 556.2324782, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

RD4-2174

[(1S,4S,5S,6R,9S,10R,12R,14R)-4-benzoyloxy-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-7-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl]methyl benzoate

C34H36O7 (556.2460906)

Ingenol 3,20-dibenzoate is a benzoate ester. Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells[1][2]. Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells[1][2].

11-Hydroxyiridodial glucoside pentaacetate

C26H36O13 (556.2155806000001)

Pyrochlorophyllide

C33H32MgN4O3 (556.2324782)

2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate

(2R)-3-hydroxy-2-{[6-O-(6-O-octanoyl-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl]oxy}propanoic acid

C23H40O15 (556.236709)

Sjg-136

C31H32N4O6 (556.2321732)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

8-epi-11-Hydroxyiridodial glucoside pentaacetate

C26H36O13 (556.2155806000001)

Glaucarubolone 15-O-beta-D-glucopyranoside

4,5,17-trihydroxy-6,14,18-trimethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-ene-9,16-dione

C26H36O13 (556.2155806000001)

Glaucarubolone 15-O-beta-D-glucopyranoside is found in fats and oils. Glaucarubolone 15-O-beta-D-glucopyranoside is a constituent of Simarouba glauca (aceituno) Constituent of Simarouba glauca (aceituno). Glaucarubolone 15-O-beta-D-glucopyranoside is found in fats and oils.

Dipiperamide C

[2,3-bis[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-(pyrrolidine-1-carbonyl)cyclobutyl]-piperidin-1-ylmethanone

C33H36N2O6 (556.2573236000001)

Dipiperamide C is found in herbs and spices. Dipiperamide C is an alkaloid from white pepper, Piper nigrum. Alkaloid from white pepper, Piper nigrum. Dipiperamide C is found in herbs and spices.

N-[4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide

N-[4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide

C30H29ClN6O3 (556.1989554)

Fluticasone propimonate

1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-2,13,15-trimethyl-5-oxo-17-(propanoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl propanoate

C28H35F3O6S (556.2106326)

Pexmetinib

N-[3-Tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-n-[(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-indazol-5-yl]oxy}phenyl)methyl]carbamimidate

C31H33FN6O3 (556.259804)

O-Desmethyl Midostaurin

N-{3-hydroxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl}-N-methylbenzamide

C34H28N4O4 (556.2110448)

PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

[(2R)-3-(acetyloxy)-2-{[(5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0)

[(2R)-2-(acetyloxy)-3-{[(5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

[(2R)-3-(acetyloxy)-2-{[(4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0)

[(2R)-2-(acetyloxy)-3-{[(4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O10P (556.2437216)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Lariciresinol-sesquilignan

1-(4-hydroxy-3-methoxyphenyl)-2-(4-{4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl}-2-methoxyphenoxy)propane-1,3-diol

C30H36O10 (556.2308356)

Lariciresinol-sesquilignan is a member of the class of compounds known as 7,9-epoxylignans. 7,9-epoxylignans are lignans that contain the 7,9-epoxylignan skeleton, which consists of a tetrahydrofuran that carries a phenyl group, a methyl group, and a benzyl group at the 2-, 3-, 4-position, respectively. Lariciresinol-sesquilignan is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lariciresinol-sesquilignan can be found in sesame, which makes lariciresinol-sesquilignan a potential biomarker for the consumption of this food product.

Aloeresin D

[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[2-[(2R)-2-hydroxypropyl]-7-methoxy-5-methyl-4-oxochromen-8-yl]oxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate

C29H32O11 (556.1944522)

Aloeresin D is a natural product found in Aloe africana, Aloe ferox, and other organisms with data available. Aloeresin D is a chromone glycoside isolated from Aloe vera, inhibits β-Secretase (BACE1) activity, with an IC50 of 39 μM[1]. Aloeresin D is a chromone glycoside isolated from Aloe vera, inhibits β-Secretase (BACE1) activity, with an IC50 of 39 μM[1].

Roritoxin D

7,8-Didehydro-14-deoxy-2,3-epoxy-2,3-dihydro-14-oxovertisporin

C29H32O11 (556.1944522)

Brianodin C

C26H36O13 (556.2155806000001)

Dracunculifoside P

C26H36O13 (556.2155806000001)

Bis-(7-hydroxygirinimbine) A

C36H32N2O4 (556.2361952)

Bu-1709E1

6-Deamino-6-hydroxybutirosin A

C21H40N4O13 (556.259175)

Iryantherin G

rel-1-[3-[(1R,2R,3S)-1,4-Bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl]-3-(4-methoxyphenyl)-1-propanone

C34H36O7 (556.2460906)

Xylogranatin M

C30H36O10 (556.2308356)

PIPERADUNCIN C

C33H32O8 (556.2097072)

Ehletianol C

C30H36O10 (556.2308356)

Roridin E acetate

(+)-Roridin E acetate

C31H40O9 (556.2672190000001)

Bis-(7-hydroxygirinimbine) B

C36H32N2O4 (556.2361952)

Kadsuphilol M

C29H32O11 (556.1944522)

8-C-Glucosyl-(2-O-cinnamoyl)-7-O-methylaloediol A

(-)-8-C-Glucosyl-(2-O-cinnamoyl)-7-O-methylaloediol A

C29H32O11 (556.1944522)

Interiotherin C

C30H36O10 (556.2308356)

A lignan with a dibenzocyclooctadiene skeleton attached to a fatty acid ester and acetate side chains. It is isolated from Kadsura ananosma and has been shown to exhibit neuroprotective activity.

Amritoside A

C26H36O13 (556.2155806000001)

Nordenletin

C33H32O8 (556.2097072)

Lanceocrepidiaside D

C29H32O11 (556.1944522)

Tinosineside A

C26H36O13 (556.2155806000001)

11beta-Acetoxyobacunyl acetate

C30H36O10 (556.2308356)

swietenin C

C31H40O9 (556.2672190000001)

Terreulactone D

C30H36O10 (556.2308356)

Thelephantin F

C33H32O8 (556.2097072)

Toosendanal

C30H36O10 (556.2308356)

Gustastatin

C31H40O9 (556.2672190000001)

A natural product found in Cupania cinerea.

Jaspolinaloside

C27H40O12 (556.251964)

Iryantherin H

rel-1-[3-[(1R,2S,3R)-1,4-Bis(4-hydroxyphenyl)-2,3-dimethylbutyl]-2,4,6-trihydroxyphenyl]-3-(4-methoxyphenyl)-1-propanone

C34H36O7 (556.2460906)

8-C-Glucosyl-(2-O-cinnamoyl)-7-O-methylaloediol B

(-)-8-C-Glucosyl-(2-O-cinnamoyl)-7-O-methylaloediol B

C29H32O11 (556.1944522)

SSR 69071

6-Methoxy-1,1-dioxo-2-[[4-oxo-9-(2-piperidin-1-ylethoxy)pyrido[1,2-a]pyrimidin-2-yl]oxymethyl]-4-propan-2-yl-1,2-benzothiazol-3-one

C27H32N4O7S (556.1991602)

CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8076; ORIGINAL_PRECURSOR_SCAN_NO 8073 CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8117; ORIGINAL_PRECURSOR_SCAN_NO 8114 CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8117; ORIGINAL_PRECURSOR_SCAN_NO 8115 CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8152; ORIGINAL_PRECURSOR_SCAN_NO 8150 CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8162; ORIGINAL_PRECURSOR_SCAN_NO 8160 CONFIDENCE standard compound; INTERNAL_ID 510; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8177; ORIGINAL_PRECURSOR_SCAN_NO 8174

Alangicadinoside E

C26H36O13 (556.2155806000001)

Kadsulignan F|kadsuralignan F

C29H32O11 (556.1944522)

20-deoxy-16-hydroxyingenol-5,16-dibenzoate

C34H36O7 (556.2460906)

C34H36O7

C34H36O7 (556.2460906)

cordyanhydride B

C29H32O11 (556.1944522)

Solenolide A

C28H41ClO9 (556.2438966000001)

23-(R)-photogedunin acetate|alpha-photogedunin acetate|beta-photogedunin acetate

C30H36O10 (556.2308356)

punaglandin 1

methyl 5S,6R,7R-triacetoxy-9-oxo-10-chloro-12S-hydroxy-10Z,14Z,17Z-prostatrienoate-cyclo[8R,12S]

C27H37ClO10 (556.2075132)

norstaminol C

C30H36O10 (556.2308356)

Macrolidine

C28H32N2O10 (556.2056852)

Antibiotic Z-1159-1

C21H40N4O13 (556.259175)

ilexin C|methyl (4E)-3-{[(2R,3R,4R,4S)-3,4-dihydro-6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxyspiro[1,3-dioxolane-4,2(1H)-naphthalen]-2-yl]methyl}-4-formylhex-4-enoate

C30H36O10 (556.2308356)

Pinobatol

C30H36O10 (556.2308356)

Kadsulignan F

C29H32O11 (556.1944522)

3a,14-dihydroxy-9,13a,15a-trimethyl-1-(2-oxo-2h-pyran-5-yl)hexadecahydro-4ah,7ah-11,12a-epoxycyclopenta[7,8]oxireno[8a,9]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-15(1h)-one

C30H36O10 (556.2308356)

2-hydroxy-3-O-isobutyrylproceranolide

C31H40O9 (556.2672190000001)

ruageanin A

C31H40O9 (556.2672190000001)

Urceolatoside B

C26H36O13 (556.2155806000001)

Leptolepisol A

C30H36O10 (556.2308356)

acetoxydehydroastin

C29H32O11 (556.1944522)

quiquelignan A

C29H32O11 (556.1944522)

11beta,12alpha-diacetoxy-1-deoxo-14beta,15beta-epoxy-3beta-hydroxy-2-oxoneotecleanin|11??,12??-Diacetoxy-1-deoxo-14??,15??-epoxy-3??-hydroxy-2-oxo-neotecleanin

C30H36O10 (556.2308356)

jashemsloside B

C27H40O12 (556.251964)

6,9-Dihydroxymegastigm-7-en-3-one 9-O-beta-D-glucopyranoside tetraacetate

C27H40O12 (556.251964)

Kwangsine

C36H32N2O4 (556.2361952)

C23H40O15

C23H40O15 (556.236709)

clausenawalline A

C36H32N2O4 (556.2361952)

(-)-(7R,8S,7S,8R)-3,3,5,5-tetramethoxy-4-hydroxy-4,7-epoxy-8,9-dinor-4,8-oxy-8,3-sesquineolignan-7,9,9-triol-7-al

C29H32O11 (556.1944522)

A neolignan isolated from the stems of Sinocalamus affinis.

threo-guaiacylglycerol-beta-O-4-lariciresinol ether

C30H36O10 (556.2308356)

scutebata L

C34H36O7 (556.2460906)

ophiorrhiside E

C28H32N2O10 (556.2056852)

lancolide A|lancolide B

C29H32O11 (556.1944522)

cydonioside A

C27H40O12 (556.251964)

andirolide J

C30H36O10 (556.2308356)

5alpha,13alpha,15beta-trihydroxy-16beta-methoxyl-1alpha,6alpha,7beta-triacetoxy-12-oxocassane-14,16-epoxy|neocaesalpin AE

C27H40O12 (556.251964)

C28H36N4O8

C28H36N4O8 (556.2533016)

picconiocoside III

C27H40O12 (556.251964)

6alpha-Acetoxyobacunol acetate

C30H36O10 (556.2308356)

methyl-2-hydroxy-3beta-isobutyroxy-1-oxomeliac-8(30)-enate

C31H40O9 (556.2672190000001)

moluccensin I

C30H36O10 (556.2308356)

hainangranatumin C

C30H36O10 (556.2308356)

jashemsloside A|picconiocoside II

C27H40O12 (556.251964)

Kadsurarin II

C30H36O10 (556.2308356)

javanicin N

C30H36O10 (556.2308356)

jasminoside F pentaacetate

C26H36O13 (556.2155806000001)

Anhydrophlegmacin

C33H32O8 (556.2097072)

sarcodonin L

C34H36O7 (556.2460906)

C31H40O9

C31H40O9 (556.2672190000001)

hainangranatumin I

C30H36O10 (556.2308356)

Glu Pro Pro Gln Ser

C23H36N6O10 (556.2492796)

Asp Glu Phe Phe

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Asp Phe Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Asp Phe Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-phenylpropanamido]pentanedioic acid

C27H32N4O9 (556.2169182)

Asp Phe Ile Tyr

(3S)-3-amino-3-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Phe Leu Tyr

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Phe Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C28H36N4O8 (556.2533016)

Asp Phe Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C28H36N4O8 (556.2533016)

Asp Ile Phe Tyr

(3S)-3-amino-3-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Ile Tyr Phe

(3S)-3-amino-3-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Leu Phe Tyr

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Leu Tyr Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Pro Tyr Tyr

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C27H32N4O9 (556.2169182)

Asp Tyr Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C28H36N4O8 (556.2533016)

Asp Tyr Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C28H36N4O8 (556.2533016)

Asp Tyr Ile Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Tyr Leu Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Asp Tyr Pro Tyr

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl}propanoic acid

C27H32N4O9 (556.2169182)

Asp Tyr Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C27H32N4O9 (556.2169182)

Glu Asp Phe Phe

(4S)-4-amino-4-{[(1S)-2-carboxy-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Glu Phe Asp Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Glu Phe Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-3-phenylpropanamido]butanedioic acid

C27H32N4O9 (556.2169182)

Glu Phe Met Met

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C24H36N4O7S2 (556.2025306)

Glu Phe Val Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Glu Phe Tyr Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Glu Met Phe Met

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C24H36N4O7S2 (556.2025306)

Glu Met Met Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C24H36N4O7S2 (556.2025306)

Glu Val Phe Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Glu Val Tyr Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Glu Tyr Phe Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Glu Tyr Val Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Phe Asp Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Phe Asp Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-phenylpropanamido]pentanedioic acid

C27H32N4O9 (556.2169182)

Phe Asp Ile Tyr

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S,2S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Phe Asp Leu Tyr

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Phe Asp Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C28H36N4O8 (556.2533016)

Phe Asp Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C28H36N4O8 (556.2533016)

Phe Glu Asp Phe

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C27H32N4O9 (556.2169182)

Phe Glu Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-3-phenylpropanamido]butanedioic acid

C27H32N4O9 (556.2169182)

Phe Glu Met Met

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C24H36N4O7S2 (556.2025306)

Phe Glu Val Tyr

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Phe Glu Tyr Val

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Phe Phe Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-carboxypropanamido]pentanedioic acid

C27H32N4O9 (556.2169182)

Phe Phe Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-carboxybutanamido]butanedioic acid

C27H32N4O9 (556.2169182)

Phe Phe Phe Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C32H36N4O5 (556.2685566)

Phe Phe Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C29H40N4O5S (556.271927)

Phe Phe Leu Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C29H40N4O5S (556.271927)

Phe Phe Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C29H40N4O5S (556.271927)

Phe Phe Met Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C29H40N4O5S (556.271927)

Phe Phe Pro Phe

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C32H36N4O5 (556.2685566)

Phe Ile Asp Tyr

(3S)-3-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Phe Ile Phe Met

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C29H40N4O5S (556.271927)

Phe Ile Met Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C29H40N4O5S (556.271927)

Phe Ile Tyr Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C28H36N4O8 (556.2533016)

Phe Leu Asp Tyr

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C28H36N4O8 (556.2533016)

Phe Leu Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C29H40N4O5S (556.271927)

Phe Leu Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C29H40N4O5S (556.271927)

Phe Leu Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C28H36N4O8 (556.2533016)

Phe Met Glu Met

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C24H36N4O7S2 (556.2025306)

Phe Met Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C29H40N4O5S (556.271927)

Phe Met Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C29H40N4O5S (556.271927)

Phe Met Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O5S (556.271927)

Phe Met Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O5S (556.271927)

Phe Met Met Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C24H36N4O7S2 (556.2025306)

Phe Met Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O6S (556.2355436)

Phe Met Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O6S (556.2355436)

Phe Asn Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H32N6O8 (556.2281512)

Phe Asn Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C26H32N6O8 (556.2281512)

Phe Pro Phe Phe

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-3-phenylpropanoic acid

C32H36N4O5 (556.2685566)

Phe Pro Met Tyr

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O6S (556.2355436)

Phe Pro Tyr Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanoic acid

C28H36N4O6S (556.2355436)

Phe Val Glu Tyr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Phe Val Tyr Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C28H36N4O8 (556.2533016)

Phe Tyr Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C28H36N4O8 (556.2533016)

Phe Tyr Asp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C28H36N4O8 (556.2533016)

Phe Tyr Glu Val

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O8 (556.2533016)

Phe Tyr Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]butanedioic acid

C28H36N4O8 (556.2533016)

Phe Tyr Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]butanedioic acid

C28H36N4O8 (556.2533016)

Phe Tyr Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O6S (556.2355436)

Phe Tyr Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C26H32N6O8 (556.2281512)

Phe Tyr Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C28H36N4O6S (556.2355436)

Phe Tyr Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]pentanedioic acid

C28H36N4O8 (556.2533016)

His His Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid